Inovio Pharmaceuticals, Inc.
Vaccines having an antigen and interleukin-21 as an adjuvant
Last updated:
Abstract:
Disclosed herein is a vaccine comprising an antigen and IL-21. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
6 Nov 2018
Issue date:
18 May 2021